Vietnam Pharmaceuticals Market Demand, Size and Competitive Analysis | TechSci Research

Vietnam Pharmaceuticals Market was valued at USD 7.60 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.96% through 2029. <table><tr><td>Pages</td><td>80</td></tr> <tr><td>Market Size</td><td>2023: USD 7.60 Billion</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 12.12 Billion</td></tr> <tr><td>CAGR</td><td>2024-2029: 7.96%</td></tr> <tr><td>Fastest Growing Segment</td><td>Generic Drugs</td></tr> <tr><td>Largest Market</td><td>South Vietnam</td></tr> <tr><td>Key Players</td><td>1.Bayer Vietnam Ltd.2.DHG Pharmaceutical Joint Stock Company3.Traphaco Joint Stock Company4.Pharmaceutical Corporation Ha Tay5.Domesco Medical Import Export Joint Stock Corporation (DOMESCO)6.OPC Pharmaceutical Joint Stock Company7.Sanofi Vietnam8.Mekophar Chemical and Pharmaceutical JSC9.Imexpharm Pharmaceutical Joint Stock Company 10.Pymepharco Joint Stock Company</td></tr> </table>

越南医药市场在2023年达到了760亿美元的价值，预计在预测期内将展现出令人瞩目的增长势头，复合年增长率（CAGR）将达到7.96%，并有望于2029年达到1212亿美元。

<table>
<tr><td>页数</td><td>80</td></tr>
<tr><td>市场规模</td><td>2023年：760亿美元</td></tr>
<tr><td>预测市场规模</td><td>2029年：1212亿美元</td></tr>
<tr><td>复合年增长率（CAGR）</td><td>2024-2029年：7.96%</td></tr>
<tr><td>增长最快的细分市场</td><td>仿制药</td></tr>
<tr><td>最大市场</td><td>越南南部</td></tr>
<tr><td>主要参与者</td><td>1.拜耳越南有限公司2.DHG制药股份有限公司3.特拉法科股份有限公司4.河内制药股份有限公司5.多美斯科进出口股份有限公司（DOMESCO）6.OPC制药股份有限公司7.赛诺菲越南8.美科法药业有限公司9.越南医药进出口股份有限公司10.皮美法股份有限公司</td></tr>
</table>